The Right Question? | GenomeWeb

The Right Question?

The US Supreme Court today is hearing arguments in the Association for Molecular Pathology et al. vs. Myriad Genetics gene patenting case, bringing up the question of whether genes, particularly isolated genes, may be patented.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Biotech Court

Open Emails

Spot for Information

Top Billing

To Know or Not?

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.